Examining the Changing Narrative for Novavax After Recent Partnerships and Strategic Shifts [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
The consensus analyst price target for Novavax stock has edged slightly lower from $13.21 to $13.11 per share. This reflects a mix of positive and cautious perspectives on the company's latest moves. As the valuation narrative continues to evolve, readers are encouraged to follow along for insights on how to stay informed about Novavax's ongoing transformation. Analyst Price Targets don't always capture the full story. Head over to our Company Report to find new ways to value Novavax. What Wall Street Has Been Saying ?? Bullish Takeaways Cantor Fitzgerald has initiated coverage of Novavax with an Overweight rating, signaling optimism regarding the company's strategic direction and prospects. The firm set a price target of $18 per share, reflecting confidence in Novavax's shift from a commercial to a licensing model and the ability to generate new revenue streams through partnerships. Analysts are encouraged by Novavax's position as the provider of the only protein-based CO
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]Yahoo! Finance
- Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]Barrons
- Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]Yahoo! Finance Canada
- Moderna Falls as FDA Vows to Impose New Vaccine Requirements [Yahoo! Finance Canada]Yahoo! Finance Canada
- FDA official, without providing data, claims link between COVID-19 vaccines and pediatric deaths [CBS News]CBS News
NVAX
Earnings
- 11/6/25 - Miss
NVAX
Sec Filings
- 11/12/25 - Form SCHEDULE
- 11/6/25 - Form 8-K
- 11/6/25 - Form 10-Q
- NVAX's page on the SEC website